Chronic sympathoexcitation is implicated in ventricular arrhythmogenesis (VAs) following myocardial infarction (MI), but the critical neural pathways involved are not well understood. Cardiac adrenergic function is partly regulated by sympathetic afferent reflexes, transduced by spinal afferent fibers expressing the TRPV1 channel. The role of chronic TRPV1 afferent signaling in VAs is not known. We hypothesized that persistent TRPV1 afferent neurotransmission promotes VAs after MI. Using epicardial Resiniferatoxin (RTX) to deplete cardiac TRPV1-expressing fibers, we dissected the role of this neural circuit in VAs after chronic MI in a porcine model. We examined the underlying mechanisms using molecular approaches, immunohistochemistry, in vitro and in vivo cardiac electrophysiology, and simultaneous cardio-neural mapping.
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Brief Summary
Cardiac sympathetic afferent reflex (CSAR) signaling promotes maladaptive adrenergic activation. Depleting chronic CSAR protects prevents ventricular arrhythmias after myocardial infarction by mitigating proarrhythmic structural remodeling. (25 words) 
INTRODUCTION
Cardiac adrenergic activation (sympathoexcitation) after myocardial infarction (MI) is a central driver of ventricular arrhythmogenesis(VAs) (3, 4) . Pharmacologic adrenergic receptor antagonism and neurohormonal blockade form the basis of clinical therapy (5) after MI, however, current therapies are inadequate in preventing VAs
The cardiac sympathetic afferent reflex (CSAR), which mediates the transduction of and sympathetic response to acute MI, contributes to the initiation, and persistence of adrenergic activation (3, (6) (7) (8) . The CSAR is enhanced in chronically injured and failing hearts (9) . The afferent limb of the CSAR is mediated partly by fibers expressing the transient receptor potential cation subfamily V member 1 (TRPV1) channel (10) , activated by heat, several metabolites generated by ischemia (e.g. bradykinin), and capsaicin. TRPV1 afferent signaling is also implicated in chronic pain (11, 12) . Chronic cardiac sympathoexcitation driven by persistent TRPV1 afferent signaling promotes adverse remodeling in rodents (13) , however, its role in arrhythmogenesis has not been explored. Further, the translational potential of this paradigm in the treatment of progressive cardiac dysfunction after MI is unknown.
To address this, we devised a strategy for cardiac-restricted targeting of TRPV1 afferents by transient percutaneous epicardial application of resiniferatoxin (RTX) (14) , a potent, selective, and irreversible activator of the TRPV1 channel that depletes fibers containing the channel. RTX was applied at the time of MI induction in pigs. Terminal experimentation was performed 4 weeks later in the following groups; control, MI treated with RTX (MI+RTX) and untreated MI subjects (MI).
Here, we demonstrate a substantial reduction in VAs in MI+RTX pigs compared to MI, mediated by amelioration of scar-border zone fibrosis and sympathetic remodeling that converge to promote electrically unstable myocardium, and VAs. These data suggest that percutaneous epicardial modulation of TRPV1 sensory afferents is a viable upstream target to mitigate chronic cardiac sympathoexcitation and its deleterious effects.
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RESULTS
Epicardial RTX application induces degeneration of TRPV1 afferent fibers.
To target cardiac-specific TRPV1-expressing afferent fibers ( Figure 1A) , we utilized a percutaneous approach to transiently apply RTX (12.5µg/ml, Supplemental Methods) to the epicardium in MI subjects. We previously established the feasibility of this approach in normal porcine (14) . Four weeks later, depletion of calcitonin gene-related peptide (CGRP), a marker of afferent fibers that co-localize with TRPV1(15), was confirmed by epicardial immunohistochemistry ( Figure 1B Given the small diameter of C-and Aδ-axons that characterize TRPV1 afferents (16) , selective loss of TRPV1 neurons would be expected to bias the distribution of DRG soma size towards larger neurons. The absence of this finding, in the presence of loss of axons indicates that epicardial RTX application caused axonal degeneration of TRPV1 afferents, not significant elimination of sensory afferent soma in the DRG. Both chemical (TRPV1-expressing) and multimodal (mechanical and chemical) cardiac afferents were likely impacted by RTX, given the expression of TRPV1 in these fibers.
Cardiac TRPV1 afferent depletion reduces ventricular arrhythmogenesis after MI
To determine whether depletion of cardiac TRPV1 afferents reduces VAs after MI, we performed programmed extra-stimulation (PES) from a right ventricular endocardial catheter, 4 weeks after antero-septal infarct in MI and MI+RTX subjects. Ventricular tachycardia (VT) or fibrillation (VF) was induced in 12/13 MI subjects (92%), but only in 1/7 MI+RTX subjects (14%) (p=0.005, Figure 2A -B). The ease of inducibility (i.e. degree of aggressiveness of the PES protocol) was quantified as the arrhythmogenicity index (AI), which was higher when fewer ventricular extra-stimuli were required for induction.
MI subjects compared to MI+RTX showed greater AI ( Figure 2C -E).
Arrhythmogenesis was also assessed by bolus intravenous administration of Cesium
Chloride (CsCl), a non-specific potassium channel antagonist that transiently elicits afterdepolarization-induced triggered activity (17) In summary, these findings thus far show that ventricular arrhythmogenesis, assessed by independent provocations, are significantly reduced by depletion of cardiac TRPV1 afferents.
TRPV1 afferent depletion does not mediate its antiarrhythmic effects by altering cardiomyocyte electrophysiology
Next, to determine the mechanisms by which cardiac TRPV1 afferent depletion reduced VAs after MI, we examined the expression of ion channels causative of VAs (18) in the scar-BZ, where post-infarct VAs typically originate (19) . Expression of SCN5A (INA), KCND2 (Ito), HERG (Ikr), KCNQ1 (Iks), and KCNJ4 (Ik1) was not different (Supplemental Figure 2A ) among control, MI, and MI+RTX subjects. Additionally, since ß-adrenergic signaling modulates ion channel function, we examined and found no differences in ß1adrenergic receptor (ß1AR) mRNA expression, protein levels, or functional responses to sympathetic stimulation (Supplemental Figure 2B ) elicited by right stellate ganglion stimulation (RSGS).
Although expression of ion channels was not different, alterations in ion channel function by cardiac TRPV1 afferent depletion may underlie the protection from VAs. To examine this possibility, we recorded action potentials (APs) from scar-BZ cardiomyocytes isolated from MI and MI+RTX subjects. We confirmed that isolated cells from MI and MI+RTX subjects exhibited no morphological differences, since RTX was applied to the epicardium directly (Supplemental Figure 3A To determine whether calcium handling, an accepted mechanism for arrhythmogenesis when dysfunctional (20) , was involved in the reduced arrhythmogenic potential observed in MI+RTX animals, we investigated Ca 2+ transients in cardiomyocytes loaded with the Ca 2+ -sensitive indicator Fluo-4. We found no significant differences in the kinetics of calcium release (time to peak) and reuptake (half maximal recovery (τ50)), as shown in Figure 4B ).
These data indicate that modulation of cardiomyocyte AP and calcium handling do not underlie the anti-arrhythmic protection conferred by cardiac TRPV1 afferent depletion following MI. It is possible that TRPV1 afferent depletion is associated with changes in the functional regulation of ion channels or calcium handling proteins, however, if these changes exist, they do not appear to translate to the cardiomyocyte AP or Ca 2+ transient properties.
Border zone electrical heterogeneity, fibrosis, and altered connexin distribution are attenuated by TRPV1 afferent depletion
The critical dependence of VAs on structural abnormalities that permit slowed and heterogeneous electrical propagation in the BZ of infarcted hearts is well established (19) . To determine whether chronic TRPV1 afferent depletion exerts its protective effects by ameliorating cardiac structural abnormalities following MI, we quantified fibrosis, a determinant of electrical propagation, and performed highresolution cardiac electrical mapping of the BZ in MI and MI+RTX subjects.
Trichrome staining of border zone myocardium demonstrated a substantial reduction in transmural fibrosis and wall thinning in MI+RTX vs MI subjects ( Figure 4A -B) in the scar-BZ, but not in remote myocardium. Next, we turned to RNA sequencing of myocardium from the scar-BZ to profile the expression of key proteins known to underlie collagen deposition following MI. As shown in Figure 4C , several genes involved in the regulation of collagen deposition after MI were differentially expressed in MI+RTX myocardium compared to MI, suggesting that several pathways key to infarct-related remodeling are impacted by cardiac TRPV1 afferent depletion.
To examine whether the reduction in fibrosis was of functional significance, we performed electrical mapping of the scar-BZ as previously published (21) . These studies demonstrated that electrical activation in scar-BZ appeared slower and more heterogeneous in MI subjects, compared to MI+RTX. Specifically, mean activation time, Connexin 43 (Cx43) distribution in the scar-BZ is known to be reduced and lateralized following MI, and is associated with VAs (22) . We examined whether TRPV1 depletion also attenuated Cx43 remodeling in its reduction of post-infarct VAs. We observed restored Cx43 distribution in MI+RTX subjects in the scar-BZ, while no significant differences were identified in myocardium remote to the infarcted region (Supplemental Figure 6 ).
In summary, these data suggest that cardiac TRPV1 afferent depletion exerts its antiarrhythmic effects by attenuating scar-BZ fibrosis, Cx43 distribution, and activation heterogeneity at the tissue level, not by altering cellular AP or tissue repolarization properties.
Depletion of cardiac TRPV1 afferents preserves global cardiac function after MI
We sought to determine whether the structural changes mitigated by TRPV1 afferent depletion at the time of MI improved cardiac function as determined by echocardiography. While MI resulted in reduced left ventricular ejection fraction (LV EF), increased LV end-systolic volume (LVESV) and internal diameter in diastole (LVIDd), and caused LV wall thinning, treatment with RTX at the time of MI attenuated these changes ( Figure 5A -E).
Chronic cardiac TRPV1 afferent signaling promotes cardiac hyperdynamic adrenergic dysfunction
Since enhanced cardiac adrenergic tone results from cardiac TRPV1 afferent activation, and is a powerful modulator of cardiac electrical function, we sought to examine whether sympathetic neuronal dysfunction (known to occur following MI) was the link between TRPV1 afferent activation and adverse BZ remodeling. This question would not be answered by ß-adrenergic receptor or calcium channel blockade, because independent of arrhythmia mechanism, ß-adrenergic receptor and calcium channel blockers are established anti-arrhythmic agents. We turned to extracellular neuronal recordings of sympathetic neurons located in the cardiac pole of the stellate ganglion (SGNs), the major nexus point for efferent adrenergic outflow to the heart. We Basal SGN activity was greater in MI compared to control subjects ( Figure 6B ).
Additionally, the proportion of neurons exhibiting spontaneous activity was greater in MI compared to control subjects ( Figure 6C ), indicating higher sympathetic tone after MI.
Both indices of enhanced adrenergic tone were attenuated by cardiac TRPV1 afferent depletion ( Figure 6B -C). The responses of SGNs to cardiovascular stimuli were used to characterize reflex processing by SGNs ( Figure 6D ). SGN responses to cardiac mechanical stress (RVP-rapid ventricular pacing), afterload increase (Ao Occ -aortic occlusion), and preload reduction (IVC Occ -inferior vena cava occlusion) caused paradoxical changes in SGNs from MI compared to control subjects. TRPV1 afferent depletion in MI subjects (MI+RTX) largely restored these response patterns to that seen in control subjects. Conditional probability analysis(1,2) was used to assess the degree of coordinated network function among cardiac-related SGNs to RVP, IVC Occ, and Ao Occ. It revealed a diminution in network processing capabilities of MI subjects compared to controls, and this was similarly normalized by cardiac TRPV1 afferent depletion ( Figure 6E ). These data indicate enhanced but uncoordinated reflex function of SGNs following MI; however, these adverse neural network processes were prevented by TRPV1 afferent depletion.
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DISCUSSION
The major findings of the present study are that chronic cardiac TRPV1 afferent signaling following MI promotes arrhythmogenic myocardium by driving deletrious Prior studies have suggested that while elimination of cardiac sympathetic innervation after MI does not reduce infarct size, it substantially reduced myocardial inflammation, myocyte hypertrophy, and cardiac dysfunction (23) . Similar findings were observed in a pressure overload model, where interstitial fibrosis was reduced by elimination of cardiac sympathetic nerves (24) . Although this influence exerted by cardiac sympathetic innervation was known, drivers of enhanced sympathetic activity remain poorly understood. We investigated the role of cardiac TRPV1 afferent signaling in this paradigm (Supplemental Figure 7) , and identified it as a key driver of enhanced adrenergic function and adverse myocardial remodeling following MI.
The findings of the present study are distinct from those in a rodent knock out model of the TRPV1 channel, where pressure overload-induced cardiac hypertrophy was exacerbated by the genetic ablation of the TRPV1 channel (25, 26) . These findings are not surprising, given the important role TRPV1 afferents play in the early disease process, where they mediate the protective responses to ischemia as an example. As a result, genetic ablation of this channel offers no protective mechanism to ischemia and cardiac stress. Chronically however, continued TPRV1 afferent signaling promotes adrenergic drive to the heart, along with its maladaptive consequences chronically. In the chronic setting, elimination of TRPV1 afferents is beneficial, but not acutely. In our study, the mechanism by which RTX eliminates TRPV1 afferent fibers (toxic excitation) enables the acute beneficial responses of cardiac TRPV1 afferents, but over the ensuing days, leads to elimination of the afferent fibers. This key difference between RTX-mediated depletion of TRPV1 afferents and genetic ablation of the TRPV1 channel are critical to differentiating the findings of our study from rodent knock out studies. Our findings are supported by MI studies in rodents treated with RTX, in which fibrosis and cardiac function was improved to a similar degree as in our porcine study, and in contrast with rodent genetic ablation studies.
Our study also highlights dysfunctional reflex processing with the stellate ganglion following MI. The stellate ganglion is a major nexus point in cardiac adrenergic signaling as a critical site for pre-to post-ganglionic synapses. However, increasingly, the stellate ganglion is recognized to have processing capabilities. The degree to which there is dysfunctional processing following MI was not well understood. In the present study, we show that MI is associated with increase neuronal firing rates, and a loss of coordinated network function in stellate ganglia. Interestingly, this loss of coordination after MI was partially attenuated by cardiac TRPV1 afferent depletion, suggesting a role for these afferent fibers in neuronal dysfunction post-MI. This highlights another pathophysiologic mechanism linking adrenergic dysfunction with cardiac injury. Importantly, while we have shown an association between chronic hyper-dynamic and uncoordinated adrenergic function and adverse remodeling after MI, although logical, these data do not specifically implicate adrenergic hyper-activation in the initiation of VT/VF.
Study Limitations
TRPV1 channels have been reported in cardiomyocytes, although the intracellular location remains controversial (27, 28) . It is unlikely that myocardial TRPV1 modulation influenced our findings because: 1) experiments were performed 4 weeks after RTX was applied; and 2) the expected effect of RTX-activation of the TRPV1 channel is an irreversible calcium influx, which would result in cell death. This did not occur as verified by histology, LV function (assessed by echocardiography), and ex vivo high-resolution gadolinium enhanced cardiac magnetic resonance imaging (MRI, 1mm voxel resolution) in normal hearts. Toxic irreversible activation of TRPV1 in cardiomyocytes would also worsen LV function after MI, not improve it as shown in the present study (Supplemental Figure 7 ). Delivery of RTX required percutaneous epicardial access, which may limit clinical translation of this approach. However, percutaneous epicardial access is increasingly 16 used for ablation and left atrial appendage closure. Genetic ablation of TRPV1 may further clarify our findings; however, such models do not exist in large animals. Although porcine subjects more closely recapitulate human pathophysiology than murine models, some caution should be exercised in extrapolating these findings to humans, given some resistance to ß-adrenergic receptor blockers in preventing VT/VF during acute ischemia in one porcine study (29) .
Conclusions
These data in composite demonstrate that epicardial RTX application in the early ischemic period is a feasible method to deplete TRPV1 sensory afferents. These afferent fibers chronically drive sympathoexcitation following MI, promoting adverse myocardial remodeling, electrical heterogeneity, and VT/VF risk (Supplemental Figure   9 ) chronically. Cardiac-restricted targeting of chronic CSAR ameliorates these pathologic processes, and renders infarcted hearts more stable and resistant to VAs.
This implicates TRPV1 afferents as key targets in reducing post-MI cardiac dysfunction and arrhythmias, to which novel minimally or non-invasive approaches can be developed. 
METHODS
See Supplemental Methods for full details.
Animal models and protocols
RTX Administration
Isoflupredone acetate (0.04mg/kg) and famotidine (0.5mg/kg) were given intramuscularly 24 hours prior to RTX administration. The left sternocostal angle was anesthetized with 1% lidocaine before making a 0.5cm-1.0cm incision. Percutaneous access to the intrapericardial space was obtained using a Tuohy needle under fluoroscopic observation (14) . A small amount of contrast agent was used to ensure the advancement of the needle tip and intrapericardial access was confirmed by cardiac ectopy and tension before entering the pericardial space. Access was confirmed by a short J-tip guidewire taking a cardiac border-forming configuration fluoroscopically. The incision was progressively dilated with 6Fr -8Fr dilators. A multipurpose sheath was then advanced over the J-tip wire in order to aspirate pericardial fluid and administer 10mL of RTX (12.5ug/mL). 20minutes later, RTX was aspirated, and methylprednisolone sodium succinate (50mg) was injected to prevent pericardial adhesions. Buprenorphine (0.02mg/kg) was administered intramuscularly starting 6 hours after the procedure and then every 24hours for 2 days. Carprofen (4mg/kg) and famotidine (20mg/day) were also orally given every 24 hours for 3 days post procedure.
In sham subjects, the protocol with repeated identically, with saline vehicle infused instead.
Isolation of Border Zone Ventricular Myocytes
Following euthanasia, border zone myocardium (adjacent but distinct from dense scar) was rapidly biopsied and 0.8cm 3 samples were placed in storage solution as described by Workman et al (30) . We then performed collagenase/protease isolation of ventricular myocytes as described (31) . Myocytes were stored at room temperature in Kraft-Bruhe solution (pH 7.4) until use within 4 hours of isolation.
Action Potential Recordings
For action potential (AP) recordings, we placed isolated cardiomyocytes in an 
Measurement of Ca 2+ transients
We loaded isolated cardiomyocytes with the Ca 2+ indicator Fluo-4 by incubating cells in bath solution containing Fluo-4 AM (10 µM) and Pluronic F-127 (0.02%) for 30 minutes, followed by three washes in dye-free bath solution for five minutes each. The loading and washout times were sufficient for de-esterification of the dye. We then recorded Fluo-4 fluorescence signals using a photodiode during simultaneous current clamp using a custom-designed photometric epifluorescence detection system attached to the patch clamp microscope described above. We used a 488 nm LED light source for excitation and a longpass filter to restrict emission to >510 nm. Fluorescence ratios were normalized to baseline (F/F0) after background subtraction.
Statistical Analysis
Variables are presented as means ± standard error (SE). The Shapiro-wilk test was used for assessing distribution. A two-tailed student's t-test and ANOVA test were used for data that were normally distributed, and the Mann-Whitney test and Kruskal-Wallis test were used for data that were not normally distributed. *Indicated statistical significance at p value < 0.05 (**denotes p value < 0.01, ***denotes p value < 0.001, ****denotes p value < 0.0001). Analysis was performed using Microsoft excel (Redmond, WA, USA) and Graphpad Prism (La Jolla, CA, USA).
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